SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications

Lancet Neurol.

Chia R, Chiò A, Traynor BJ

doi: 10.1016/

Amyotrophic Lateral Sclerosis

Cortical correlates of behavioural change in amyotrophic lateral sclerosis

J Neurol Neurosurg Psychiatry.

Consonni M, Cappa SF, Dalla Bella E, Contarino VE, Lauria G

doi: 10.1136/jnnp-2018-318619.

Amyotrophic Lateral SclerosisAlzheimer’s DiseaseDementia

Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum

JAMA Neurol.

Karch CM, Wen N, Fan CC, Yokoyama JS, Kouri N, Ross OA, Höglinger G, Müller U, Ferrari R, Hardy J, Schellenberg GD, Sleiman PM, Momeni P, Hess CP, Miller BL, Sharma M, Van Deerlin V, Smeland OB, Andreassen OA, Dale AM, Desikan RS; International Frontotemporal Dementia (FTD)–Genomics Consortium, International Collaboration for Frontotemporal Dementia, Progressive Supranuclear Palsy (PSP) Genetics Consortium, and International Parkinson’s Disease Genomics Consortium.

doi: 10.1001/

Amyotrophic Lateral Sclerosis

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

JAMA Neurol.

Zhao W, Beers DR, Hooten KG, Sieglaff DH, Zhang A, Kalyana-Sundaram S, Traini CM, Halsey WS, Hughes AM, Sathe GM, Livi GP, Fan GH, Appel SH

doi: 10.1001/

Amyotrophic Lateral SclerosisDementia

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

JAMA Neurol.

Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Sorarù G

doi: 10.1001/jamaneurol.

Amyotrophic Lateral Sclerosis

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis

JAMA Neurol.

Lunetta C, Lizio A, Maestri E, Sansone VA, Mora G, Miller RG, Appel SH, Chiò A

doi: 10.1001/jamaneurol.

Amyotrophic Lateral Sclerosis

Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients

Brain Behav.

Feddermann-Demont N, Junge A, Weber KP, Weller M, Dvořák J, Tarnutzer AA

doi: 10.1002/brb3.630.

Amyotrophic Lateral Sclerosis

Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis

Front Mol Neurosci.

Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D'Errico E, Scarafino A, Distaso E, Simone IL

doi: 10.3389/fnmol.2018.00288.

Amyotrophic Lateral Sclerosis

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Lancet Neurol.

Writing Group, Edaravone (MCI-186) ALS 19 Study Group

doi: 10.1016/

Related content

Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications

Cortical correlates of behavioural change in amyotrophic lateral sclerosis

Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis

Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients

Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial